NANO Nuclear Energy (NASDAQ:NNE) stock fell 8% in premarket trade after it priced its underwritten public offering of 900K shares and warrants to purchase 450K. Each share and associated warrant is being sold at $20.00 apiece, for gross proceeds of ~$18 million. The warrants are exercisable immediately, have a term of fiveContinue Reading
bunhill Stock futures edged higher early Friday following cooling CPI data ahead of big bank earnings due later today. Here are some of Friday’s biggest stock movers: Biggest stock gainers Following Q2 results, Ericsson’s (NASDAQ:ERIC) stock price rose more than 7% despite a 7% Y/Y dip in revenue, as theContinue Reading
aluxum United Therapeutics (NASDAQ:UTHR) traded lower on Thursday after Morgan Stanley downgraded the Tyvaso maker to Equal Weight from Overweight, citing a balanced risk-reward setup following strong gains this year. Morgan Stanley said that United Therapeutics (UTHR), which markets drugs for a lung disorder called pulmonary arterial hypertension (PAH), hasContinue Reading
JamesBrey Almost three quarters of the top 10 stocks’ current valuations come from expectations for future earnings growth, according to research by DataTrek. Between 60% and 90% of the current valuations for the U.S. big tech stocks are based on future growth expectations, compared to about 55% for the S&PContinue Reading
phototechno Abeona Therapeutics (NASDAQ:ABEO) traded higher on Thursday after the company announced a partnership with eye care drug developer Beacon to evaluate its patented technology, AAV204, for gene therapies. Per the terms, Beacon, which belongs to Syncona’s clinical portfolio of companies, will have a non-exclusive right to evaluate AAV204 capsidContinue Reading
ibreakstock/iStock via Getty Images Biodexa (NASDAQ:BDRX) stock shot up 70% in morning trading Thursday after the company re-released positive data from a Phase 2 study for its drug eRapa in the treatment of Familial Adenomatous Polyposis, for FAP. According to the company’s release Thursday, 12-month data from the Phase 2Continue Reading
hatchapong/iStock Editorial via Getty Images Visa (NYSE:V) disclosed on Wednesday that it will release ~$2.7B from its series B and series C convertible participating preferred stock in connection with the third mandatory release assessment on June 21, 2024. The release comes on the eighth anniversary of the Visa Europe acquisitionContinue Reading
bill oxford/iStock via Getty Images LL Flooring (NYSE:LL) surged 17% after holder F9 Investments said that its three nominees were added to the board. All three F9 nominees, Tom Sullivan, Jason Delves, and Jill Witter, were elected to the board at the annual meeting based on preliminary voting results, accordingContinue Reading
spawns Amylyx Pharmaceuticals (NASDAQ:AMLX) traded sharply higher on Wednesday after the drug developer announced the acquisition of avexitide, a GLP-1 receptor antagonist developed by Eiger BioPharmaceuticals (OTC:EIGRQ). The transaction was completed on July 9 after Amylyx (AMLX) emerged as the winning bidder in an auction held to sell Avexitide underContinue Reading
Jin_Youngin/iStock via Getty Images Vestis Corp (NYSE:VSTS) fell 4% despite some takeover speculation for the uniform maker. There’s some speculation that Vestis (VSTS) has attracted acquisition interest potentially from a larger rival, according to a Betaville “uncooked” alert on Wednesday, which cited people following the matter. Shares of Vestis (VSTS)Continue Reading
